News Releases

Wednesday, April 23, 2014

Study shows Aspirin can reduce colorectal cancer risks for those with specific gene

CLEVELAND/BOSTON – The humble aspirin may have just added another beneficial effect beyond its ability to ameliorate headaches and reduce the risk of heart attacks: lowering colon cancer risk among people with high levels of a specific type of gene.
 
The extraordinary finding comes from a multi-institutional team that analyzed data and other material from two long-term studies involving nearly 128,000 participants. The researchers found that individuals whose colons have high levels of a specific gene product — 15-hydroxyprostaglandin dehydrogenase (15-PGDH) RNA — dramatically reduce their chances of developing colorectal cancer by taking aspirin. In contrast, the analgesic provides no benefit to individuals whose colons show low levels of 15-PGDH. About half of the population possesses high levels of 15-PGDH.

Browns hire Dr. James Voos as head team physician
Monday, April 21, 2014

Browns hire Dr. James Voos as head team physician

 
BEREA – The Cleveland Browns have hired James Voos, M.D., as the club’s head team physician, General Manager Ray Farmer announced on Thursday. Dr. Voos, a respected orthopedic surgeon entering his sixth year in the NFL, will direct the Browns’ multidisciplinary team of medical specialists, manage pivotal aspects of the club’s comprehensive health-care needs and collaborate with Browns head athletic trainer Joe Sheehan.
 
“As a former NFL player, I have a special understanding of a medical staff’s significance and impact,” said Farmer. “Especially knowing Dr. Voos’ reputation with the Chiefs, I’m confident this staff, working in conjunction with Joe Sheehan and his staff, will be a strong addition to our team’s overall health and well-being, on and off the field. Personally and professionally, I'm excited for the opportunity to work with Dr. Voos.”
 
In addition to spending three seasons with the Kansas City Chiefs (2011-13) and two with the New York Giants (2009-10), Dr. Voos has dedicated more than 10 years to aiding athletes at the professional, college and high-school levels. 

Friday, April 04, 2014

Heart attack gene, MRP-14, triggers blood clot formation

CLEVELAND – Right now, options are limited for preventing heart attacks. However, the day may come when treatments target the heart attack gene, myeloid related protein-14 (MRP-14, also known as S100A9) and defang its ability to produce heart attack-inducing blood clots, a process referred to as thrombosis.

Scientists at Case Western Reserve School of Medicine and University Hospitals Case Medical Center have reached a groundbreaking milestone toward this goal. They have studied humans and mice and discovered how MRP-14 generates dangerous clots that could trigger heart attack or stroke, and what happens by manipulating MRP-14. This study describes a previously unrecognized platelet-dependent pathway of thrombosis. The results of this research will appear in the April edition of The Journal for Clinical Investigation (JCI).

Wednesday, March 26, 2014

UH Case Medical Center offers first catheter ablation therapy approved in the U.S. with direct contact force technology for treatment of atrial fibrillation

CLEVELAND – University Hospitals (UH) Case Medical Center is among the first in the country to offer the THERMOCOOL®  SMARTTOUCH® Catheter, the first catheter approved by the Food and Drug Administration (FDA) in the U.S. to feature direct contact force technology for the treatment of patients with atrial fibrillation, or Afib.
 
This novel innovation enables doctors to accurately control the amount of contact force applied to the heart wall during radiofrequency catheter ablation procedures. 

Thursday, March 20, 2014

University Hospitals named one of Ethisphere's 2014 World's Most Ethical Companies

CLEVELAND – University Hospitals (UH) has been recognized by the Ethisphere Institute, an independent center of research promoting best practices in corporate ethics and governance, as one of the 2014 World’s Most Ethical Companies®.
 
This is the second time that the UH health system has received this honor (it previously received the recognition in 2012) and it is one of eight health systems worldwide to be named to this year’s list.


You must be logged in to view this item.



Login

This area is reserved for members of the news media. If you qualify, please update your user profile and check the box marked "Check here to register as an accredited member of the news media". Please include any notes in the "Supporting information for media credentials" box. We will notify you of your status via e-mail in one business day.